Paid Clinical Trials Newark

Discover 252 paid clinical trials in Newark, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 252

IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Newark DE, Baltimore MD, Boston MA, Oshawashow 10 more

Code:

NCT04557462

Conditions

Primary IgA Nephropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LNP023

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Newark DE, Elkton MD, Wilmington DE, Chadds Ford PAshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & DaratumumabS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Newark DE, Elkton MD, Wilmington DE, Chadds Ford PAshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Wilmington DE, Philadelphia PA, Baltimore MD, Hershey PAshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Newark DE, Philadelphia PA, Towson MD, Lutherville MDshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Observational StudyRhizomelic Chondrodysplasia Punctata Registry

Recruiting

Sponsor:

Nemours Children's Clinic

Location:

Wilmington DE

Code:

NCT04569162

Conditions

RCDP - Rhizomelic Chondrodysplasia Punctata

RCDP1

RCDP2

RCDP3

RCDP4

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

SaruparibSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Newark DE, Bala-Cynwyd PA, Philadelphia PA, Camden NJshow 115 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Observational StudyUniversity of Delaware Parkinson's Disease Registry

Recruiting

Sponsor:

University of Delaware

Location:

Newark DE

Code:

NCT04496973

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

OxytocinOxytocin Rest to Reduce Cesarean Delivery

Recruiting

Sponsor:

Christiana Care Health Services

Location:

Newark DE

Code:

NCT06268431

Conditions

Prolonged Labor

Failed Induction

Labor Dystocia

Eligibility Criteria

Sex: Female

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Oxytocin rest

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Newark DE, Philadelphia PA, Reading PA, Lutherville MDshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide